Methenamine Hippurate (Alvogen Inc.)
Welcome to the PulseAid listing for the Methenamine Hippurate drug offered from Alvogen Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen Inc. |
NON-PROPRIETARY NAME: | Methenamine Hippurate |
SUBSTANCE NAME: | METHENAMINE HIPPURATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-05-03 |
END MARKETING DATE: | 0000-00-00 |
Methenamine Hippurate HUMAN PRESCRIPTION DRUG Details:
Item Description | Methenamine Hippurate from Alvogen Inc. |
LABELER NAME: | Alvogen Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/1) |
START MARKETING DATE: | 2010-05-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-577_7a9dfd96-da64-0144-cd7f-21e1d756e738 |
PRODUCT NDC: | 47781-577 |
APPLICATION NUMBER: | NDA016151 |
Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers: